FIELD: pharmaceutics.
SUBSTANCE: present invention relates to compounds or pharmaceutically acceptable salts thereof of general formula I, where R1 is ; R2 is selected from a group consisting of substituted or unsubstituted phenyl and
,
and
; and R3, R4, R5 and R6 all denote H, as well as to compounds II and III.
EFFECT: invention also relates to pharmaceutical compositions based on said compounds, method of activating a Wnt signal transmission, methods of treating diseases associated with signal transduction, and use thereof for treating such diseases as osteoporosis and osteoarthropathy; imperfect osteogenesis, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, head face defects, oncolytic bone disease, traumatic brain injury, relating to differentiation and developing central nervous system, including Parkinson's disease, stroke, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; eye diseases, such as age-related macular degeneration, diabetic macular oedema or pigment pigmentosa and disease related to differentiation and growth of stem cells, including hair loss, disease related to hematopoiesis, and diseases associated with tissue regeneration.
39 cl, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MIMETICS WITH REVERSE CONFIGURATIONS AND METHODS OF THEIR ADMINISTRATION | 2004 |
|
RU2342387C2 |
IMPROVED DIFFERENTIATION METHOD | 2017 |
|
RU2772435C2 |
GAMMA-DIKETONES AS WNT/BETA-CATENIN SIGNALING PATHWAY ACTIVATORS | 2014 |
|
RU2680716C2 |
CONDITIONED ENVIRONMENT AND COMPOSITION BASED ON EXTRACELLULAR MATRIX FROM CELLS CULTIVATED IN HYPOXIC CONDITIONS | 2010 |
|
RU2631488C2 |
INDAZOLIE WNT SIGNAL PATHWAY INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | 2017 |
|
RU2682245C1 |
INDASOLE INHIBITORS OF Wnt SIGNAL PATH AND THEIR THERAPEUTIC APPLICATIONS | 2013 |
|
RU2638932C2 |
ANTICANCER AGENT | 2016 |
|
RU2729936C2 |
COMPOSITION FOR STIMULATING HAIR GROWTH AND PREVENTING HAIR LOSS | 2019 |
|
RU2794988C1 |
N-(2-THIAZOLYL)AMIDE DERIVATIVES AS GSK-3 INHIBITORS | 2007 |
|
RU2429237C2 |
ALPHA-SPIRAL MIMETICS AND METHODS ASSOCIATED WITH THEM | 2009 |
|
RU2512538C2 |
Authors
Dates
2016-07-27—Published
2011-08-17—Filed